Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
Contents:; Chronic Pain and Opioids -- Current Cost of the Opioid Epidemic -- Opioid Use Disorder -- History and Legality of Cannabis -- Overview of the Endocannabinoid System (ECS) -- Cannabinoids and Terpenes -- Synthetic Cannabinoid Pharmaceuticals -- Isolate Cannabinoid Pharmaceuticals -- Medic…
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
This first of its kind book is a comprehensive compilation of multiple facets of cannabis recommendation, use and effects from a variety of different perspectives. Comprised of chapters dedicated to separate fields of medicine, this evidence-based guide outlines the current data, or lack thereof, a…
PART I: INTRODUCTION AND BACKGROUND; 1 INTRODUCTION; 2 CANNABIS; 3 CANNABIS: PREVALENCE OF USE, REGULATION, AND CURRENT POLICY LANDSCAPE; PART II: THERAPEUTIC EFFECTS; 4 THERAPEUTIC EFFECTS OF CANNABIS AND CANNABINOIDS; PART III: OTHER HEALTH EFFECTS; 5 CANCER; 7 RESPIRATORY DISEASE; 8 IMMUNITY; 9…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency SUR Library | Available |
Contents:; 1. Mechanism of Chemotherapy in Cancer Treatment -- 2. Neutropenic Complications of Chemotherapy -- 3. Chemotherapy Induced Anemia -- 4. Cancer Treatment Related Thrombocytopenia -- 5. Oral Mucositis -- 6. Gastrointestinal Complications of Chemotherapy -- 7. Neurological Complications --…
Contents:; Cellular mechanisms of chemotherapy -- Pharmacologic principles of chemotherapy -- Pharmacogenomics and chemotherapy -- Principles and standards of antineoplastic therapy administration -- Administration of hazardous drugs in the perioperative setting -- Immunotherapy : agents and target…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
Contents:; Chapter 1 Epidemiology of Cardio-Oncology -- Chapter 2 Cardiotoxicity of Anticancer Therapies -- Chapter 3 Screening and Monitoring for Cardiotoxicity during Cancer Treatment -- Chapter 4 Management of Chemotherapy-Associated Cardiomyopathy -- Chapter 5 Treatment of hypertension in patie…
"This poster presents the target organs for all agents classified as carcinogenic to humans (Group 1) by the IARC Monographs Programme (in red), and for the interventions showing sufficient evidence of a cancer-preventive effect in the IARC Handbooks of Cancer Prevention (in green)."